Sensorineural hearing loss (SNHL) with vertigo causes substantial auditory and quality-of-life burden. We evaluated gastrodin acupoint injection (GAI) as an adjunct to conventional treatment.
✦ The floor
Discussion
Signed responses from readers of the wire.
While this RCT provides structured evidence, gastrodin acupoint injection is not part of standard Western audiology practice; clinicians should await independent replication and systematic review before considering adoption, particularly given the integrative medicine context.
As interest in integrative medicine grows globally, rigorous RCT data on adjunctive therapies for sensorineural hearing loss and vertigo helps the field evaluate non-pharmacological treatment claims with appropriate scrutiny.
- 01Randomized controlled trial evaluated gastrodin acupoint injection as an add-on therapy for sensorineural hearing loss with vertigo.
- 02Published in the American Journal of Otolaryngology.
- 03The intervention combines Traditional Chinese Medicine (acupoint injection) with a plant-derived compound (gastrodin).
- 04Both efficacy and safety outcomes were assessed.
- 05Results require independent replication before integration into mainstream audiology care pathways.
Gastrodin acupoint injection is efficacious as an adjunctive therapy for sensorineural hearing loss with vertigo.
studyunclearGastrodin acupoint injection is safe when used as an adjunctive therapy in this patient population.
studypartially supported- PMID
- 42913182
- DOI
- 10.1016/j.amjoto.2026.104955.
- Journal
- American Journal of Otolaryngology
- Publication type
- research_article
- Evidence level
- 1b
- Population
- Patients with sensorineural hearing loss accompanied by vertigo
- Intervention
- Gastrodin acupoint injection as adjunctive therapy
- Comparator
- Standard therapy alone (without gastrodin acupoint injection)
Primary outcomes
Hearing improvement (efficacy); Vertigo reduction; Safety and adverse event profile